GCP
ARRY

GSA Capital Partners’s Array Biopharma Inc ARRY Stock Holding History

GSA Capital Partners’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-11,674
Closed -$166K – 1836
2018
Q4 		$166K Buy
+11,674
New +$177K 0.02% 1145
2018
Q2 		– Sell
-12,746
Closed -$208K – 2068
2018
Q1 		$208K Buy
+12,746
New +$204K 0.01% 1459
2017
Q3 		– Sell
-148,485
Closed -$1.24M – 1995
2017
Q2 		$1.24M Buy
148,485
+101,179
+214% +$827K 0.08% 398
2017
Q1 		$423K Buy
+47,306
New +$503K 0.02% 1194
2016
Q4 		– Sell
-81,085
Closed -$547K – 2064
2016
Q3 		$547K Buy
+81,085
New +$314K 0.03% 1006
2016
Q1 		– Sell
-36,293
Closed -$153K – 2035
2015
Q4 		$153K Sell
36,293
-128,748
-78% -$588K 0.01% 1692
2015
Q3 		$753K Buy
165,041
+90,146
+120% +$534K 0.04% 859
2015
Q2 		$540K Buy
74,895
+41,617
+125% +$307K 0.02% 1311
2015
Q1 		$245K Buy
+33,278
New +$237K 0.01% 1829
2014
Q3 		– Sell
-16,714
Closed -$76K – 2024
2014
Q2 		$76K Buy
+16,714
New +$69.1K ﹤0.01% 1735
2013
Q4 		– Sell
-34,486
Closed -$215K – 1831
2013
Q3 		$215K Sell
34,486
-40,400
-54% -$240K 0.02% 1354
2013
Q2 		$340K Buy
+74,886
New +$403K 0.04% 798

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

GSA Capital Partners's ARRY Position: Q1 2019 in Review

GSA Capital Partners sold out of Array Biopharma Inc (ARRY) in Q1 2019, closing a stake of 11,674 shares — an estimated $166K sold.

GSA Capital Partners first reported a position in ARRY in Q2 2013 and held it in 12 quarters. The position peaked at $1.24M in Q2 2017. 268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

  • GSA Capital Partners reported no remaining Array Biopharma Inc position as of Q1 2019 after selling out during the quarter.
  • GSA Capital Partners sold 11,674 Array Biopharma Inc shares in Q1 2019, an estimated $166K.
  • GSA Capital Partners first reported a position in Array Biopharma Inc in Q2 2013 and held it in 12 quarters.
  • GSA Capital Partners's Array Biopharma Inc position peaked at $1.24M in Q2 2017.
  • 268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.